BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

Three CJEU decisions that answer some questions but pose many more

09 July 2014

Journal of Intellectual Property Law & Practice (2014) 9 (7): 599-604
Author: Mike Snodin

This article first appeared online on 22 April 2014 in the Journal of Intellectual Property Law and Practice. It reviews, analyses and comments upon the decisions in cases C-443/12 (Actavis v Sanofi), C-484/12 (Georgetown University) and C-493/12 (Eli Lilly v HGS). Whilst noting areas that have been clarified and speculating upon strategies that may now represent "best practice" in the light of the decisions, the article also points out the many areas of uncertainty that still remain - or that have been generated by the decisions.

We have placed cookies on your device to help make this website better. You can click the link below to disable cookies, otherwise, we'll assume you're happy to continue
Close This Notice

Disable Cookies | 3rd Party Data Processors